BMS-025 is an orthogonal STING agonist that can induce chemical shifts in the STINGM271 residue, thereby further activating STINGIFN signal transduction. BMS-025 is applicable in the study of monogenic autoinflammatory diseases such as SAVI.
Target-Kategorie:
STING
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
